Companies/Atlantic International Corp.

Company profile

Atlantic International Corp.

NASDAQ: ATLN · Healthcare · Medical - Diagnostics & Research

PublicHQ Billerica, MACIK 0001605888Reports USD

#220 of 1,394 Healthcare companies by revenue38th-percentile growth

EA Score

39D

FH 45DQ 22GM 46SS 51

v0.1 · 65/100 weight · provisional

↑ 3-yr revenue growth, workforce scale · ↓ growth stability, Piotroski F

Methodology →

Revenue TTM

$583.0M

Rev growth YoY (TTM)

+31.1%

Net income (FY)

-$59.4M

Employees

300

Market cap

$73.2M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$435.9M$435.9M2025

Net income-$59.4M-$59.4M2025

Operating income-$50.2M-$50.2M2025

Total assets$113.2M$113.2M2025

Liabilities$145.3M$145.3M2025

Equity-$32.1M-$32.1M2025

Revenue trend

FY2021 – FY2025 · USD

$278.9k

FY21

$162.0k

FY21

$77.5k

FY22

$401.4M

FY24

$442.6M

FY24

$435.9M

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Atlantic International Corp. booked $435.9M in FY2025 revenue, contracting 1.5% year over year — slower than 62% of Healthcare companies we track, at a -13.6% net margin.

Peers · Healthcare

MindWalk Holdings Corp.——NDT Pharmaceuticals Inc.——electroCore, Inc.56C Pliant Therapeutics, Inc.49D

Key facts

CEOJeffrey Jagid

SectorHealthcare

IndustryMedical - Diagnostics & Research

HeadquartersBillerica, MA

ExchangeNASDAQ: ATLN

Employees300

IPO date2021-08-27

Latest filings

8-K2026-07-01 8-K2026-06-25 10-Q2026-06-22 10-K2026-04-15 8-K2026-04-03 8-K2026-03-26 8-K2026-02-03 8-K2026-01-28

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.